Drug Policy Alliance (DPA) explains the decriminalisation model in Oregon, its reversal after a misinformation campaign, and the costs and harms of recriminalisation.
The OHCHR summarises discussions on the need for a rights- and evidence- based approach to drug policy, including decriminalisation, harm reduction, legal regulation and structural changes to the global drug control regime.
Nelson et al. investigate the many tactics street dealers use to mitigate risks of police harassment, arrest, and violence, and call on the government to focus on systemic rather than law enforcement solutions.
Busz et al. offer an account of the evolution of Dutch harm reduction and the ongoing need for reinvestment in harm reduction infrastructure and rights-based solutions.
Zoorob et al. reveal fentanyl as a large driver of the US overdose epidemic, whilst dispelling misconceptions about the effect of Oregon's drug decriminalisation policies on rises in mortality and overdose rates.
PRI offers analysis of global challenges, including overcrowding, mental health issues, corruption, and the growing use of digital technologies, whilst also showcasing innovative solutions toward reform.
IDPC and LBHM critically assess the country's punitive drug policies and their impact on prison overcrowding, recommending increased health-oriented provision and legal reforms.
IDPC discusses alternative measures to incarceration implemented in Thailand from the perspectives of practitioners and people involved in the criminal legal system.
The UNSR on the right to health highlights global harm reduction practices, urging states to abandon punitive approaches to safeguard marginalised populations' rights for sustainable peace and development.
Rouhani et al. explore how US prosecutors use harm reduction principles to shape criminal justice outcomes for people who use drugs, revealing the potential for pro-drug policy reform.
CERD calls attention to the disproportionate impact of the criminal legal system on racialised people and groups, urging the UK to consistently apply anti-discrimination laws and engage in relevant policy reform.
Brown's overview urges government bodies to prioritise gender-sensitive care in harm reduction services, highlighting the need for targeted funding and support for women who use drugs.
